Fate Therapeutics (FATE) Interest Coverage Ratio Growth (3y) (2016 - 2019)
Fate Therapeutics (FATE) Interest Coverage Ratio Growth (3y) (2016 - 2019) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
29.25% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
-16.86% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Fate Therapeutics |
250.86 Mn |
250.86 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2019 |
-27.71% |
| Sep 30, 2019 |
-45.99% |
| Jun 30, 2019 |
-48.46% |
| Mar 31, 2019 |
-47.19% |
| Dec 31, 2018 |
-44.62% |
| Sep 30, 2018 |
-54.52% |
| Jun 30, 2018 |
-53.23% |
| Mar 31, 2018 |
-37.49% |
| Dec 31, 2017 |
-6.56% |
| Sep 30, 2017 |
5.09% |
| Jun 30, 2017 |
40.63% |
| Mar 31, 2017 |
38.52% |
| Dec 31, 2016 |
-21.51% |
| Sep 30, 2016 |
0.89% |
| Jun 30, 2016 |
27.61% |
| Mar 31, 2016 |
22.15% |
